Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-27469905

RESUMO

Higher doses of cefazolin are required in obese patients for preoperative antibiotic prophylaxis, owing to its low lipophilicity. An ultra high performance liquid chromatography-tandem mass spectrometry method was developed to quantify cefazolin in serum and adipose tissue from 6 obese patients undergoing cesarean delivery, and using stable-isotope labeled cefazolin as an internal standard. The method has a 2µg/g lower limit of quantitation. The concentration in adipose tissue was 3.4±1.6µg/mL, which is less than half of the reported minimum inhibitory concentration of 8µg/mL for cefazolin. Serum cefazolin concentrations were more than 30-fold higher than in adipose tissue.


Assuntos
Tecido Adiposo/metabolismo , Antibacterianos/metabolismo , Cefazolina/metabolismo , Cesárea , Cromatografia Líquida de Alta Pressão/métodos , Obesidade/metabolismo , Espectrometria de Massas em Tandem/métodos , Tecido Adiposo/química , Adulto , Antibacterianos/sangue , Cefazolina/sangue , Feminino , Humanos , Obesidade/sangue , Projetos Piloto , Gravidez
2.
J Matern Fetal Neonatal Med ; 23(8): 906-13, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19895351

RESUMO

OBJECTIVE: Obstetrical risk is increased with maternal obesity. This prospective study was designed to simultaneously evaluate the outcomes in obese parturients and their newborns. METHODS: Patients with a body mass index (BMI) > or =35 were prospectively identified and compared to an equal number of normal weight parturients. Maternal and neonatal outcome measures were compared for the peripartum and neonatal period. RESULTS: We identified 580 obese parturients over a 6 month period and compared them to an equal number of normal weight parturients. The incidence of obesity in this population was 23%. Obesity was associated with increased rates of hypertension, diabetes, and cesarean section. Obese patients were more likely to develop postpartum complications. Neonatal outcomes were compared for infants > or =37 weeks gestation excluding multiple births (496 neonates in the obese group and 520 in the control group). The neonates of obese parturients were more likely to be macrosomic, have 1-minute Apgar scores of < or =7.0 and require admission to a special care unit. Sub-group analysis showed that negative outcomes for parturients and their neonates correlated with increasing BMI. Neonates born to obese diabetic parturients had the highest risk of poor outcomes. CONCLUSIONS: Maternal obesity confers increased risks for both the parturient and their newborn.


Assuntos
Peso ao Nascer , Recém-Nascido , Obesidade/epidemiologia , Complicações na Gravidez/epidemiologia , Índice de Apgar , Índice de Massa Corporal , Feminino , Humanos , Manitoba/epidemiologia , Gravidez , Gravidez em Diabéticas/epidemiologia , Estudos Prospectivos
3.
Can J Anaesth ; 50(9): 922-5, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14617590

RESUMO

PURPOSE: To report and discuss a case of fetal bradycardia in a parturient under anesthesia for cholecystectomy despite normal maternal oxygenation and arterial blood pressure. CLINICAL FEATURES: A 27-yr-old woman (gravida 2 para 1), with a fetus of 34 weeks gestation, received general anesthesia for cholecystectomy. After anesthesia induction and tracheal intubation, anesthesia was maintained with oxygen, sevoflurane and iv remifentanil infusion. While preparing for surgery, the fetal heart rate decreased within about half a minute to 70 beats x min(-1) and remained at that level. The maternal blood pressure, heart rate and oxygen saturation were normal. An emergency Cesarean delivery was performed. The infant had Apgar scores of 1 at one minute, 5 at five minutes, 7 at ten minutes and required resuscitation after birth. CONCLUSION: Ideally, women having non-obstetric surgery during the third trimester of pregnancy will have intraoperative fetal heart rate monitoring.


Assuntos
Pressão Sanguínea/fisiologia , Bradicardia/etiologia , Colecistectomia/efeitos adversos , Sofrimento Fetal/etiologia , Oxigênio/sangue , Adulto , Anestesia Geral , Anestésicos Inalatórios/administração & dosagem , Anestésicos Intravenosos/administração & dosagem , Índice de Apgar , Pressão Sanguínea/efeitos dos fármacos , Cesárea , Feminino , Monitorização Fetal , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Frequência Cardíaca Fetal , Humanos , Recém-Nascido , Éteres Metílicos/administração & dosagem , Oxigênio/administração & dosagem , Piperidinas/administração & dosagem , Gravidez , Remifentanil , Índice de Gravidade de Doença , Sevoflurano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA